Literature DB >> 21419697

Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation.

Rawiphan Witoonpanich1, Charungthai Dejthevaporn, Arporn Sriphrapradang, Teeratorn Pulkes.   

Abstract

OBJECTIVE: To determine the diagnostic sensitivity of repetitive nerve stimulation (RNS), single fiber electromyography (SFEMG) and acetylcholine receptor antibody (AChRAb) in myasthenia gravis (MG), and to compare the degree of SFEMG abnormality between ocular and generalized MG and between seronegative and seropositive patients.
METHODS: The sensitivities of RNS, SFEMG and AChRAb were estimated. SFEMG abnormality was compared between ocular and generalized MG and between seronegative and seropositive patients.
RESULTS: Abnormal RNS, abnormal SFEMG and AChRAb were detected in 62%, 93% and 38% of 42 ocular, and 80%, 99% and 73% of 70 generalized cases, respectively. The degree of SFEMG abnormality was significantly greater in the generalized than ocular patients and was significantly greater in the seropositive than seronegative patients in both extensor digitorum communis and orbicularis oculi muscles.
CONCLUSION: SFEMG is a very sensitive and useful test for MG. A correlation between SFEMG abnormality and clinical phenotype or severity and between SFEMG abnormality and AChRAb seropositivity was demonstrated. SIGNIFICANCE: The sensitivities of RNS, SFEMG and AChRAb in the diagnosis of MG were documented. The differences in severity between the ocular and generalized MG and between the seronegative and seropositive MG were confirmed and quantitatively determined by SFEMG.
Copyright © 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419697     DOI: 10.1016/j.clinph.2011.02.026

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  5 in total

1.  Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies.

Authors:  Raed Behbehani; Abdullah Ali; Ashraf Al-Moosa
Journal:  Neuroophthalmology       Date:  2022-03-15

2.  Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations.

Authors:  Michael F Seldin; Omar K Alkhairy; Annette T Lee; Janine A Lamb; Jon Sussman; Ritva Pirskanen-Matell; Fredrik Piehl; Jan J G M Verschuuren; Anna Kostera-Pruszczyk; Piotr Szczudlik; David McKee; Angelina H Maniaol; Hanne F Harbo; Benedicte A Lie; Arthur Melms; Henri-Jean Garchon; Nicholas Willcox; Peter K Gregersen; Lennart Hammarstrom
Journal:  Mol Med       Date:  2015-11-10       Impact factor: 6.354

3.  Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis.

Authors:  Giorgia Sciacca; Ester Reggio; Giovanni Mostile; Alessandra Nicoletti; Filippo Drago; Salvatore Salomone; Mario Zappia
Journal:  Neurol Sci       Date:  2018-01-12       Impact factor: 3.307

4.  Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.

Authors:  Sijia Zhao; Xu Yan; Jiaqi Ding; Kaixi Ren; Shuyu Sun; Jiarui Lu; Chao Zhang; Kai Zhang; Zhuyi Li; Jun Guo
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

Review 5.  Bedside and laboratory diagnostic testing in myasthenia.

Authors:  Katie Yoganathan; Alexander Stevenson; Awais Tahir; Ross Sadler; Aleksandar Radunovic; Naveed Malek
Journal:  J Neurol       Date:  2022-02-10       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.